As of 2025-07-02, the Relative Valuation of Cortexyme Inc (CRTX) is (26.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.95 USD, the upside of Cortexyme Inc based on Relative Valuation is -1476.5%.
The range of the Relative Valuation is (17.87) - (34.52) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.6x - 25.3x | 19.0x |
| Forward P/E multiples | 13.1x - 27.7x | 20.4x |
| Fair Price | (17.87) - (34.52) | (26.84) |
| Upside | -1016.5% - -1870.1% | -1476.5% |
| Date | P/E |